Clicky

Thursday, January 21st, 2021

CARB-X awards $2.48 million for antimicrobial research

CARB-X, a partnership between U.K. and U.S. organizations, has awarded $2.48 million to Amicrobe Inc. for development of a bioengineered antimicrobial designed to help infected tissue. Presently, the World Health Organization estimates drug-resistant infections kill 700,000 per year. In the... Read More »